Equities analysts expect that Universal Health Services, Inc. (NYSE:UHS) will report $2.63 billion in sales for the current fiscal quarter, Zacks reports. Six analysts have provided estimates for Universal Health Services’ earnings. The highest sales estimate is $2.64 billion and the lowest is $2.60 billion. Universal Health Services reported sales of $2.48 billion during the same quarter last year, which would suggest a positive year-over-year growth rate of 6%. The company is scheduled to announce its next earnings report on Tuesday, February 27th.

On average, analysts expect that Universal Health Services will report full-year sales of $2.63 billion for the current financial year, with estimates ranging from $10.37 billion to $10.42 billion. For the next fiscal year, analysts expect that the firm will post sales of $10.90 billion per share, with estimates ranging from $10.82 billion to $10.97 billion. Zacks Investment Research’s sales averages are a mean average based on a survey of sell-side research analysts that that provide coverage for Universal Health Services.

Universal Health Services (NYSE:UHS) last released its quarterly earnings data on Wednesday, October 25th. The health services provider reported $1.49 earnings per share for the quarter, missing the consensus estimate of $1.76 by ($0.27). The company had revenue of $2.51 billion for the quarter, compared to the consensus estimate of $2.60 billion. Universal Health Services had a return on equity of 15.13% and a net margin of 6.90%. The business’s revenue was up 4.4% compared to the same quarter last year. During the same period in the prior year, the business earned $1.60 earnings per share.

Several equities research analysts have recently weighed in on the company. Piper Jaffray Companies reissued a “buy” rating and set a $117.00 price objective on shares of Universal Health Services in a research note on Friday, October 27th. Zacks Investment Research lowered Universal Health Services from a “hold” rating to a “sell” rating in a research note on Saturday, January 6th. Goldman Sachs Group assumed coverage on Universal Health Services in a research note on Wednesday, January 3rd. They set a “buy” rating and a $137.00 price objective for the company. Credit Suisse Group assumed coverage on Universal Health Services in a research note on Thursday, November 2nd. They set an “outperform” rating and a $126.00 price objective for the company. Finally, BMO Capital Markets assumed coverage on Universal Health Services in a research note on Monday, October 16th. They set an “outperform” rating and a $125.00 price objective for the company. Two analysts have rated the stock with a sell rating, three have issued a hold rating and eleven have assigned a buy rating to the company. The stock presently has an average rating of “Buy” and a consensus target price of $130.50.

Institutional investors have recently modified their holdings of the company. Crossmark Global Holdings Inc. purchased a new stake in shares of Universal Health Services during the third quarter worth $205,000. Cambridge Investment Research Advisors Inc. purchased a new stake in shares of Universal Health Services during the second quarter worth $211,000. Advisor Group Inc. raised its holdings in shares of Universal Health Services by 198.0% during the second quarter. Advisor Group Inc. now owns 1,812 shares of the health services provider’s stock worth $220,000 after acquiring an additional 1,204 shares in the last quarter. Zeke Capital Advisors LLC purchased a new stake in shares of Universal Health Services during the third quarter worth $228,000. Finally, Veritable L.P. raised its holdings in shares of Universal Health Services by 16.6% during the second quarter. Veritable L.P. now owns 1,925 shares of the health services provider’s stock worth $235,000 after acquiring an additional 274 shares in the last quarter. 86.07% of the stock is owned by institutional investors and hedge funds.

Shares of Universal Health Services (UHS) opened at $116.05 on Thursday. The firm has a market capitalization of $11,049.31, a price-to-earnings ratio of 15.94, a PEG ratio of 2.46 and a beta of 0.97. The company has a debt-to-equity ratio of 0.80, a quick ratio of 1.16 and a current ratio of 1.26. Universal Health Services has a one year low of $95.26 and a one year high of $129.74.

Universal Health Services announced that its Board of Directors has approved a stock buyback program on Wednesday, November 15th that allows the company to repurchase $400.00 million in shares. This repurchase authorization allows the health services provider to buy shares of its stock through open market purchases. Shares repurchase programs are typically an indication that the company’s leadership believes its stock is undervalued.

ILLEGAL ACTIVITY WARNING: This story was first posted by American Banking News and is owned by of American Banking News. If you are viewing this story on another website, it was copied illegally and reposted in violation of U.S. and international copyright law. The original version of this story can be read at https://www.americanbankingnews.com/2018/01/18/2-63-billion-in-sales-expected-for-universal-health-services-inc-uhs-this-quarter.html.

About Universal Health Services

Universal Health Services, Inc is a holding company. The Company’s principal business is owning and operating, through its subsidiaries, acute care hospitals and outpatient facilities, and behavioral healthcare facilities. The Company’s segments include Acute Care Hospital Services, Behavioral Health Services and Other.

Get a free copy of the Zacks research report on Universal Health Services (UHS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Universal Health Services (NYSE:UHS)

Receive News & Ratings for Universal Health Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Universal Health Services and related companies with MarketBeat.com's FREE daily email newsletter.